Marissa Leigh Di Napoli, MD | |
169 Ashley Avenue, Room 202 Main Hospital, Msc333, Charleston, SC 29425-8905 | |
(843) 792-4638 | |
Not Available |
Full Name | Marissa Leigh Di Napoli |
---|---|
Gender | Female |
Speciality | Surgery |
Location | 169 Ashley Avenue, Charleston, South Carolina |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1720655939 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | LL86005 (South Carolina) | Primary |
Mailing Address | Practice Location Address |
---|---|
Marissa Leigh Di Napoli, MD 169 Ashley Avenue, Room 202 Main Hospital, Msc333, Charleston, SC 29425-8905 Ph: (843) 792-4638 | Marissa Leigh Di Napoli, MD 169 Ashley Avenue, Room 202 Main Hospital, Msc333, Charleston, SC 29425-8905 Ph: (843) 792-4638 |
News Archive
A cesarean birth had little impact on whether a child would go onto develop allergies, a new study led by the Murdoch Children's Research Institute has shown.
In the ongoing fight against costly and potentially fatal catheter related bloodstream infections, landmark clinical data presented at the 21st Annual Scientific Meeting of the Society for Healthcare Epidemiology of America demonstrates that both the exposed end of IV administration sets and catheter luer access valves are colonized by the microbes that cause CRBSI.
WHO Director-General Margaret Chan on Tuesday rejected recent criticisms that her decisions to declare H1N1 (swine flu) a pandemic were impacted by her advisers' link to the pharmaceutical industry, the Associated Press reports.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, driven by the continued dominance of opioids that include immediate-release morphine and novel fast acting opioid reformulations, the cancer pain drug market will increase from $2.3 billion in 2008 to $3.7 billion in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
K-V Pharmaceutical Company, a specialty pharmaceutical company, announced today that it has been informed by Hologic, Inc. that a resubmission to the FDA's Complete Response action letter received in January 2009 has been submitted for Gestiva™ (hydroxyprogesterone caproate injection), 250 mg/mL.
› Verified 5 days ago
Dr. Michael Charles O'laughlin, MD Surgery Medicare: Medicare Enrolled Practice Location: 169 Ashley Avenue, Room 202 Main Hospital Msc333, Charleston, SC 29425 Phone: 843-792-3072 | |
Kyler Perry, DO Surgery Medicare: Medicare Enrolled Practice Location: 169 Ashley Ave Rm 202, Charleston, SC 29425 Phone: 843-792-2300 | |
Dr. Swathi Venattu, MD Surgery Medicare: Medicare Enrolled Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Dr. Antwana Sharee Wright, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Jacob Arthur Klapper, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Norman Robert Harvey, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-2123 | |
Hyejin Kwon, MD Surgery Medicare: Medicare Enrolled Practice Location: 169 Ashley Ave, Charleston, SC 29425 Phone: 843-792-3072 |